Users Manual Part 1

IBA | xxii | Clinical User’s Guide
Volume 1 - Treatment Session
15. Preliminary results of a phase II trial of proton radiotherapy for pediatric
rhabdomyosarcoma. Ladra, MM, et al. 33, Boston : s.n., 2014, Journal of Clinical
Oncology, Vol. 32.
16. Proton radiotherapy for pediatric central nervous system ependymoma: clinical
outcomes for 70 patients. MacDonald, SM, et al. Boston : s.n., 2013, Neuro-
Oncology, Vol. 15, pp. 1552-1559.
17. Proton radiotherapy for pediatric tumors: review of first clinical results. Rombi,
B, et al. Trento : s.n., 2014, Italian Journal of Pediatrics, Vol. 40.
18. Proton radiotherapy for pediatric Ewing's sarcoma: Initial clinical outcomes.
Rombi, B, et al. 3, Trento : s.n., 2012, Int J Radiat Oncol Biol Phys, Vol. 82, pp.
1142-1148.
19. Proton therapy for spinal ependymomas: Planning, acute toxicities, and
preliminary outcomes. Amsbaugh, MJ, et al. 5, Houston : s.n., 2012, Int J Radiat
Oncol Biol Phys, Vol. 83, pp. 1419-1424.
20. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical
outcomes and dosimetry compared to intensity modulated radiation therapy.
Cotter, SE, et al. 5, Boston : s.n., 2011, Int J Radiat Oncol Biol Phys, Vol. 81, pp.
1367-1373.
21. Craniopharyngioma and Proton Therapy. Bradley, JA et Indelicato, DJ.
Jacksonville : s.n., 2014, International Journal of Particle Therapy, pp. 386-398.
22. Early cognitive outcomes following proton radiation in pediatric patients with
brain and central nervous system tumors. Pulsifer, MB, et al. 2, Boston : s.n.,
2015, Int J Radiat Oncol Biol Phys, Vol. 93, pp. 400-407.
23. Proton beam therapy versus conformal photon radiation therapy for childhood
craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and
toxicity. Bishop, AJ, et al. 2, Houston : s.n., 2014, Int J Radiat Oncol Biol Phys,
Vol. 90, pp. 354-361.
24. Proton radiotherapy for pediatric sarcoma. Ladra, MM et Yock, TI. Boston : s.n.,
2014, Cancer, Vol. 6, pp. 112-127.
25. Outcomes and acute toxicities of proton therapy for pediatric atypical
teratoid/rhabdoid tumor of the CNS. McGovern, SL, et al. 5, Houston : s.n., 2014,
Int. J. Radiat. Oncol. Biol. Phys., Vol. 90, pp. 1143-1152.
26. Incidence of CNS injury for a cohort of 111 patients treated with proton therapy
for medulloblastoma: LET and RBE associations for areas of injury. Giantsoudi,
D, et al. 1, Boston : s.n., 2016, Int J Radiat Oncol Biol Phys, Vol. 95, pp. 287-296.
27. Involved-node proton therapy in combined modality therapy for Hodgkin
lymphoma: results of a phase 2 study. Hoppe, BS, et al. 5, Jacksonville : s.n.,
2014, Int J Radiat Oncol Biol Phys, Vol. 89, pp. 1053-1059.
28. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by
proton beam therapy. Mahdjoubi, A, et al. Paris : s.n., 2018, Graefes Arch Clio
Exp Ophthalmol, pp. 411-420.